Home » Merck Pulls Bid for EU Approval of Zolinza
Merck Pulls Bid for EU Approval of Zolinza
Merck & Co has withdrawn its bid to get EU approval for its cutaneous T-cell lymphoma drug Zolinza, said the European regulator, the EMEA.
CNBC
CNBC
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May